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Western blot (immunoblot) analysis of sera from cattle vaccinated with Brucella abortus S19 exhibit an
elevated serologic response to Hsp62, the GroEL homolog (BaGroEL). Serologic screening of individual cows
vaccinated with B. abortus S19 revealed no correlation between the immune response to BaGroEL and protec-
tion against a challenge with virulent organisms. The humoral immune response to BaGroEL was restricted
to a region of the mature protein which mapped to amino acids 317 to 355 and may represent a useful diag-
nostic tool for monitoring exposure to B. abortus. Immunity to a challenge with virulent B. abortus S2308 was
not observed in the BaGroEL vaccinated mouse model.
Brucella abortus is a facultative intracellular bacterial patho-
gen that causes disease in both animals and humans. Live,
attenuated B. abortus S19 has been used as a vaccine for many
years to control bovine brucellosis (21). However, knowledge
of protective immunity against brucellosis, especially in cattle,
is incomplete (13, 18, 20). Evidence from the murine model
indicates that both humoral and cellular immune responses
participate in protective immunity against brucellosis (4). In
the murine model, the O-polysaccharide antigen and proteins
are an important part of protective immunity against brucel-
losis, but such vaccines have not been successful in cattle de-
spite numerous published and unpublished attempts (1, 19).
However, protein antigens responsible for protective immunity
have not been characterized.
BaGroEL is a member of the family of GroEL homologs
(10, 16, 23). Recently, heat shock proteins including BaGroEL
have been found to be immunodominant targets of both the
humoral and cellular immune responses (11, 14, 16, 23, 25, 28).
The immunodominance of BaGroEL is presumably related to
its abundant expression which is induced during infection of
macrophages (17). However, results from other intracellular
pathogens have suggested the use of GroEL homologs as po-
tential vaccine candidates because of their potent antigenicity.
To evaluate the potential role of BaGroEL as a vaccine, we
first examined the humoral immune response in cattle vacci-
nated with B. abortus S19. The immunoprotective capacity in
mice was subsequently characterized by challenge with B. abor-
tus S2308.
B. abortus localizes in the phagosomes or phagolysosomes of
macrophages (12), but not all Brucella cells survive in this
inhospitable environment (27). Killed Brucella cells release
proteins including BaGroEL which are processed and pre-
sented on the surface of macrophages. Generally, antigen pro-
cessing takes place within the endosomes of macrophages or
other antigen-presenting cells. Processed antigen in combi-
nation with major histocompatibility complex molecules are
presented to T cells which stimulate an immune response. In
this context, BaGroEL would represent a potential target for
natural killer cells; however, similarities to host proteins may
prevent such reactions.
(This work was conducted in partial fulfillment of the re-
quirements for the Ph.D. degree awarded to J. Lin by Texas
A&M University. Portions of this work were presented at the
92nd General Meeting of the American Society for Microbi-
ology, New Orleans, La.)
To characterize the immune response directed against
BaGroEL, bovine sera obtained from individual outbred ani-
mals (Bos taurus 3 B. indicus) vaccinated with strain S19 were
examined via Western blot (immunoblot) analysis. A humoral
immune response in all animals was detected against a protein
band at 62 kDa identified as BaGroEL on the basis of its
appearance only in heat-shocked B. abortus (Fig. 1 and data
not shown). Multiple bands migrating between positions cor-
responding to 32.5 and 49.5 kDa have been tentatively identi-
fied as the O antigen that is expressed by the RB51 isolate used
to prepare the Western blot strips and is a potent stimulator of
the humoral immune response in both cattle and mice (24, 29,
30). A monoclonal antibody specific for the type A O antigen
of B. abortus (19) reacted with the same series of bands (data
not shown). These bands are missing from rfb mutants follow-
ing transposon insertion within the rfb locus (3). Of course,
point mutations may not have as dramatic an effect on O-
antigen production. No discernible correlation was observed
between the recognition of BaGroEL and the ability (Fig. 1,
lanes 1 to 6) or inability (Fig. 1, lanes 7 to 12) of S19 vaccina-
tion to protect cows from infection (2).
The small number of protein bands which appeared to be
recognized by the bovine sera stimulated a more careful eval-
uation of the immune response directed against BaGroEL.
The possibility that successfully vaccinated cows recognized
portions of BaGroEL different from those recognized by cows
which were not successfully vaccinated led to the construction
of N-terminal and C-terminal deletions by using the maltose-
binding protein (MBP) system (pMAL-c; New England Bio-
labs, Inc.). Recombinant plasmids were constructed as shown
in Fig. 2A and B. Fusion products were purified by amylose
affinity chromatography as described by the manufacturer, and
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electrophoresis was performed as described in the legend to
Fig. 1.
Plasmid pEL contains more than 96% of the BaGroEL
coding sequence (amino acids 22 to 544) (Fig. 2B). Six deletion
constructs, designated plasmids pC-65, pC-41, pC-21, pN-26,
pN-13, and pN-6, were examined with regard to orientation
and sequence. pN-26, pN-13, and pN-6 utilized the Brucella
stop codon at the 39 end of groEL. Both pC-41 and pC-21 used
the rrnB terminator derived from pMAL-c downstream of
the cloning sites. pC-65 was translated in frame with LacZa,
which was confirmed by the observed low-level b-galactosi-
dase activity of this recombinant. Fusion products of F(MBP-
BaGroEL) were purified from transformed Escherichia coli by
amylose affinity chromatography as recommended by the
manufacturer. Rabbit anti-BaGroEL serum detected all of the
fusion products (Fig. 3A) and also reacted with smaller pro-
teins tentatively identified as degradation products on the basis
of their adherence to and elution from amylose affinity col-
umns and their absence from cells infected with the vector
alone.
In contrast to that of rabbit sera, the reactivity of pooled
bovine sera was restricted primarily to two fusion proteins,
pC-41 and pN-26 (Fig. 3B, lanes 2 and 5). The observed rec-
ognition of pC-41 and pN-26 suggests the presence of an
epitope(s) within the region flanked by amino acids 317 and
433, which are poorly recognized in the native protein (Fig.
3B, lane 1) but may be potentially recognized as a result of
processing during infection. Comparison among GroEL ho-
mologs revealed greater diversity within the region bounded by
amino acids 317 and 355 than amino acids 359 and 433 (16)
(Table 1). This region may represent a diagnostically signifi-
cant antigen capable of accurately determining exposure to
B. abortus.
These observations are reminiscent of the serological re-
sponses to Chlamydia trachomatis, Mycobacterium tuberculosis,
and M. leprae GroEL, in which most of the immunodominant
epitopes are located within the carboxyl-terminal portion of
the molecule (6, 32). For these bacteria, the serological re-
sponse was also directed against the nonconserved regions of
GroEL homologs. Precise mapping of epitopes with synthetic
peptides will resolve whether there are Brucella-specific epi-
topes in this region, especially amino acids 317 to 355, which
varies widely among GroEL homologs.
Protective immunity was determined directly by using the
mouse model. Differences between the bovine and murine
immune response have been frequently described and repre-
sent a significant problem in the interpretation of results ob-
tained with the mouse model. Nevertheless, the mouse model
has been shown to be economical and a reasonable predictor
of the immunogenic potential of vaccines and virulence poten-
tial (9, 26). BaGroEL was expressed as a fusion product of
F(MBP-BaGroEL) (Fig. 2C) and purified from transformed
E. coli by amylose affinity chromatography, cleavage with Fac-
tor Xa, and separation from MBP following a second passage
through the amylose affinity column. Protective immunity was
tested in specific-pathogen-free BALB/c mice (Jackson Labo-
ratory) which were divided into five groups of 10 animals.
Each mouse was inoculated twice subcutaneously with 10 mg of
recombinant BaGroEL in the presence or absence of RIBI
adjuvant (RIBI Immunochem Research, Inc.) in a final volume
of 0.1 ml on days 0 and 21. Control mice were inoculated
with 0.1 ml containing either RIBI adjuvant and phosphate-
buffered saline (PBS) on days 0 and 21 or 5 3 104 CFU of
B. abortus S19 per ml on day 0. Mice were challenged by
intraperitoneal injection of 6.4 3 104 infectious B. abortus
S2308 cells on day 42. Blood samples were taken retro-orbitally
on days 25 and 35. Anti-BaGroEL activity present in the sera
of inoculated mice was examined by Western blotting with
strips of whole-cell extracts of B. abortus RB51 heat shocked at
448C for 1 h. Serum was separated from cells by centrifugation
(Adams Micro-Hematocrit centrifuge; Clay-Adams, Inc.) for
FIG. 1. Western blot analysis of the serological response of vaccinated cattle
to B. abortus. Sera from individual animals representing vaccine success–culture-
negative (lanes 1 to 6) and vaccine failure–culture-positive (lanes 7 to 12) groups
were used at a dilution of 1:500. Total cell proteins of B. abortus RB51 heat
shocked at 448C were separated by sodium dodecyl sulfate–12.5% polyacryl-
amide gel electrophoresis. Western blotting, incubation with a secondary anti-
body, and color development were performed as previously described (8). Anti-
BaHsp62 rabbit serum was used as a positive control. MW, molecular mass.
TABLE 1. Amino acid similarities of BaHsp62 epitopes
Species
% Similarity to BaHsp62
Amino acids
317–355
Amino acids
359–433
Overall
sequence
Rhizobium meliloti 82.0 86.0 87.2
E. coli 58.0 73.7 67.0
Legionella pneumophila 56.4 75.0 65.3
Chlamydia psittaci 58.0 69.7 61.0
Mycobacterium bovis BCG 48.7 61.8 58.9
Mus musculusa 30.8 54.2 50.6
a Hsp60, the bovine homolog has not been sequenced.
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FIG. 2. Construction of F(MBP-BaGroEL) fusion vectors. Plasmid pEL (B) was derived by insertion of an EcoRV-EcoRI restriction fragment containing most of
the BaGroEL gene inserted into StuI-EcoRI-digested pMAL-c (A). C terminally truncated fusion products (C) were generated by restriction digestion of plasmid pEL
with XbaI, end filling with 40 mM a-thiodeoxynucleoside triphosphates, and digestion with EcoRI to generate an exonuclease III-susceptible end. Construction of N
terminally truncated fusion products (C) was performed by digestion of pBluescript containing a 2.8-kbp fragment which contains the B. abortus groESL locus with SalI
and SacI (multiple cloning site). This product was digested with exonuclease III and then EcoRI and then religated into StuI-EcoRI-digested pMAL-c. Foreign peptides
were expressed in E. coli linked to the C-terminal portion of MBP and purified by using MBP’s affinity for cross-linked amylose. The fusion products also contained
the recognition sequence (Ile-Glu-Gly-Arg) for protease, factor Xa.
TABLE 2. Vaccination of mice with BaHsp62 or B. abortus S19
Groupa
Procedureb on day: Mean spleen wt
(mg) 6 SD
Mean log10
CFU 6 SD P value
c
25 0 21 36 42 49
PBS B V V B C N 303 6 49 5.387 6 0.296
BaGroEL B V V B C N 305 6 55 5.316 6 0.364 #0.375
BaGroEL-RIBId B V V B C N 278 6 66 5.247 6 0.349 #0.375
RIBI B V V B C N 292 6 63 5.421 6 0.36 .0.4
S19 B V ND B C N 227 6 49 3.189 6 0.822 #0.0005
a There were 10 mice per group.
b Vaccine dose, 10 mg of Hsp62 in PBS or in RIBI; 5 3 104 CFU of B. abortus S19. B, blood collection; V, vaccination; ND, not done; N, necropsy; C, challenge
exposure to 6.4 3 104 CFU of B. abortus S2308.
c The probability values shown are for differences between the CFU counts of PBS-injected and vaccinated mice calculated by the Student t test.
d RIBI, RIBI adjuvant (MPL plus TDM plus CWS emulsion).
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5 min, and sera were pooled by group. At 1 week postinfection,
splenic weights and B. abortus CFU in the spleen were deter-
mined as the index of protection (19). The viable B. abortus in
the spleen was cultured on Farrell’s medium plates with or
without 0.1% (wt/vol) erythritol for differentiation of B. abor-
tus S19 and S2308 (7). The level of bacteria in each spleen was
obtained by averaging triplicate plate counts following log con-
version. Statistical significance was determined by using the
Student t test.
While mice immunized with B. abortus S19 provided sig-
nificant protection against challenge as indicated by splenic
weights and CFU counts, immunization of mice with BaGroEL
did not provide significant protection against challenge with
B. abortus S2308 (Table 2). Mice immunized with B. abortus
S19 exhibit strong reactivity against BaGroEL and additional
proteins of 90, 70, 15, and 10 kDa as detected by Western blot
analysis (Fig. 4). These data suggest that the humoral immune
response in mice is different from that observed in cattle (com-
pare Fig. 1 and 4). The immunodominant bands in mice cor-
respond to BaGroEL and four unidentified proteins of 90, 70,
15, and 10 kDa (perhaps a GroES homolog). In contrast, the
immunodominant bands in cattle correspond to BaGroEL and
lipopolysaccharide.
An antibody response against BaGroEL occurs in animals
either infected with B. abortus or vaccinated with B. abortus
S19 as described here and in previous reports (16, 23). Im-
munization with GroEL homologs has been demonstrated to
increase macrophage activation (22). It has also been postu-
lated that heat shock proteins contribute to the elicitation of a
protective immune response (31). In this study, however, im-
munization of mice with BaGroEL produced a humoral re-
sponse to BaGroEL but failed to elicit protection against a
challenge with B. abortus S2308. The result is consistent with
those reported for Bordetella pertussis (5) and Treponena pal-
lidum (15).
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